ATE330625T1 - Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits - Google Patents

Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits

Info

Publication number
ATE330625T1
ATE330625T1 AT02785892T AT02785892T ATE330625T1 AT E330625 T1 ATE330625 T1 AT E330625T1 AT 02785892 T AT02785892 T AT 02785892T AT 02785892 T AT02785892 T AT 02785892T AT E330625 T1 ATE330625 T1 AT E330625T1
Authority
AT
Austria
Prior art keywords
kit
pharmaceutical composition
retinitis pigmentosa
enzymatic treatment
enzymes
Prior art date
Application number
AT02785892T
Other languages
English (en)
Inventor
Paola Ammannati
Roberto Giordani
Original Assignee
Paola Ammannati
Roberto Giordani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paola Ammannati, Roberto Giordani filed Critical Paola Ammannati
Application granted granted Critical
Publication of ATE330625T1 publication Critical patent/ATE330625T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01021—Aldehyde reductase (1.1.1.21), i.e. aldose-reductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01049—Glucose-6-phosphate dehydrogenase (1.1.1.49)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01009—Glutathione peroxidase (1.11.1.9)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/13—Dipeptidases (3.4.13)
    • C12Y304/13009—Xaa-Pro dipeptidase (3.4.13.9) i.e. prolidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT02785892T 2002-10-01 2002-10-01 Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits ATE330625T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2002/000624 WO2004030693A1 (en) 2002-10-01 2002-10-01 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit

Publications (1)

Publication Number Publication Date
ATE330625T1 true ATE330625T1 (de) 2006-07-15

Family

ID=32051201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02785892T ATE330625T1 (de) 2002-10-01 2002-10-01 Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits

Country Status (12)

Country Link
US (1) US7445777B2 (de)
EP (1) EP1545590B1 (de)
JP (1) JP2006504715A (de)
CN (1) CN1321691C (de)
AT (1) ATE330625T1 (de)
AU (1) AU2002349813A1 (de)
BR (1) BR0215896A (de)
CA (1) CA2500068A1 (de)
DE (1) DE60212729T2 (de)
ES (1) ES2266601T3 (de)
NZ (1) NZ538969A (de)
WO (1) WO2004030693A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008501783A (ja) * 2004-06-08 2008-01-24 アンマナーティ、パオラ 網膜色素変性症の酵素治療及びキットの形態のそのための関連医薬組成物
US20110021974A1 (en) * 2010-10-05 2011-01-27 Shantha Totada R Retinitis pigmentosa treatment and prophalaxis
WO2015031119A1 (en) 2013-08-26 2015-03-05 Health Research, Inc. Method for prophylaxis and/or treatment of erbb2 positive cancers
CN107075490A (zh) 2014-08-20 2017-08-18 健康研究公司 用于预防和/或治疗erbb1阳性癌症的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784030B1 (fr) * 1998-10-02 2002-12-20 Inst Nat Sante Rech Med Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine
FR2784898A1 (fr) * 1998-10-26 2000-04-28 Univ Pasteur Utilisation du gdnf pour le traitement de la degenerescence retinienne

Also Published As

Publication number Publication date
EP1545590A1 (de) 2005-06-29
DE60212729T2 (de) 2007-06-28
ES2266601T3 (es) 2007-03-01
NZ538969A (en) 2006-06-30
US20060134088A1 (en) 2006-06-22
DE60212729D1 (de) 2006-08-03
US7445777B2 (en) 2008-11-04
AU2002349813A1 (en) 2004-04-23
CA2500068A1 (en) 2004-04-15
CN1321691C (zh) 2007-06-20
CN1671411A (zh) 2005-09-21
BR0215896A (pt) 2005-08-09
WO2004030693A1 (en) 2004-04-15
EP1545590B1 (de) 2006-06-21
JP2006504715A (ja) 2006-02-09

Similar Documents

Publication Publication Date Title
GEP20094666B (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2003089619A3 (en) Placental derived stem cells and uses thereof
WO2005082341A3 (en) NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
TW200504078A (en) Therapeutically active compounds and their use
WO2003014336A1 (en) Process for preparing hematopoietic stem cells
EP1670450B8 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
AU2003293555A1 (en) 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2004010937A3 (en) Method of treating cancer
WO2004089296A3 (en) Improved inhibitors for the soluble epoxide hydrolase
BRPI0307349B8 (pt) processo para fermentar uma composição de fitoesterol
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
WO2004052236A3 (en) Methods and compositions for treatment of otitis media
AU2003233172A1 (en) Methods compositions and articles of manufacture for modulating bone growth
WO2006063055A3 (en) Enzyme conjugates for use as detoxifying agents
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
DE60212729D1 (de) Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits
IL187489A0 (en) Novel substrate for rpn 11 enzymatic activity
WO2005074655A3 (en) Materials and method for promotion of nerve regeneration
WO2004048411A3 (en) Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
PT1441708E (pt) Composições e métodos para aumentar a observância de terapias utilizando inibidores da aldeído desidrogenase e para tratar alcoolismo
WO2004044000A3 (en) Compounds and methods for modulating functions of classical cadherins
NO20073610L (no) Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase
MXPA05006408A (es) Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos.
AU2002232127A1 (en) Method for the processing of leather
TW200738255A (en) Methods of regulating renalase (Monoamine Oxidase C)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1545590

Country of ref document: EP

REN Ceased due to non-payment of the annual fee